Antibodies Assay Kits Biology Cells cDNA Devices DNA DNA Templates DNA Testing Enzymes Equipments Isotypes NATtrol Panel PCR Pcr Kits Peptides Recombinant Proteins Test Kits
Genetic Architecture of Flowering Time and Sex Determination in Hemp ( Cannabis sativa L.): A Genome-Wide Association Study
Flowering time and intercourse dedication in hemp (Hashish sativa L.) strongly affect fiber high quality and seed manufacturing of this crop. The management of those traits is paramount for the breeding of recent cultivars. But, little is thought in regards to the genetics underlying such complicated traits and a greater understanding requires in depth data of the molecular mechanisms accountable for these traits. On this report, the genetic structure of flowering time and intercourse dedication in hemp was studied utilizing a Genome-Large Affiliation Research (GWAS) method.
Affiliation research have been carried out on a panel of 123 hemp accessions, examined in three contrasting environments, utilizing a set of 600 Ok SNP markers. Altogether, eight QTLs have been recognized throughout environments; six for flowering time traits and two for intercourse dedication. These QTLs lined genomic areas with 33 transcripts predicted to be concerned in flowering and intercourse dedication in addition to a microRNA, miR156. Genes associated to notion and transduction of sunshine and transcription elements well-known to manage flowering have been recognized in QTLs for flowering time traits. Transcription elements and genes concerned in regulating the steadiness of phytohormones, specifically auxins and gibberellic acid, have been recognized in QTLs for intercourse dedication. Intercourse dedication QTLs have been related to the event of male flowers in feminine vegetation and thus with the steadiness of intercourse dedication in monecious vegetation.
The current examine elucidates related data on the genetic mechanisms of flowering and intercourse dedication traits in hemp, and offers new instruments for hemp breeding. African swine fever (ASF) is a contagious viral illness that causes excessive mortality, approaching 100%, in home pigs and wild boars. The illness has neither a remedy nor a vaccine, and it’s attributable to an ASF virus (ASFV), the one member of the household Asfarviridae, genus Asfivirus, and the one recognized DNA arbovirus. Twenty-four genotypes of ASFV have been described to this point, and all of them have been described in Africa. ASF is endemic in Burundi, and a number of other outbreaks have been reported within the nation; the illness continues to economically affect on small-scale farmers. This examine geared toward genetic characterization of ASFV that prompted an ASF outbreak within the Rutana area, Burundi, within the 12 months 2018. Tissue samples from home pigs that died on account of a extreme hemorrhagic illness have been collected to be able to verify the illness utilizing polymerase chain response (PCR) and to conduct partial genome sequencing.
Generally hidden however all the time there: the assumptions underlying genetic inference of demographic histories
Demographic processes immediately have an effect on patterns of genetic variation inside modern populations in addition to future generations, permitting for demographic inference from patterns of each present-day and previous genetic variation. Advances in laboratory procedures, sequencing and genotyping applied sciences prior to now many years have resulted in huge will increase in high-quality genome-wide genetic knowledge from present-day populations and allowed retrieval of genetic knowledge from archaeological materials, often known as historic DNA. This has resulted in an explosion of labor exploring previous modifications in inhabitants dimension, construction, continuity and motion.
Nevertheless, as genetic processes are extremely stochastic, patterns of genetic variation solely not directly replicate demographic histories. Consequently, previous demographic processes should be reconstructed utilizing an inferential method. This often entails evaluating noticed patterns of variation with mannequin expectations from theoretical inhabitants genetics. Numerous approaches have been developed primarily based on totally different inhabitants genetic fashions that every include assumptions in regards to the knowledge and underlying demography. On this article I evaluation a few of the key fashions and assumptions underlying essentially the most generally used approaches for previous demographic inference and their penalties for our capability to hyperlink the inferred demographic processes to the archaeological and local weather data. This text is a part of the theme problem ‘Cross-disciplinary approaches to prehistoric demography’.
Genetic and Useful Range of Pseudomonas aeruginosa in Sufferers With Power Obstructive Pulmonary Illness
Pseudomonas aeruginosa is essentially the most related pathogen to the extreme exacerbations of sufferers with continual obstructive pulmonary illness (COPD). Nevertheless, the genetic and practical traits of P. aeruginosa isolates from COPD airways nonetheless stay much less understood. On this examine, the genetic, phylogenetic, phenotypic, and transcriptional options of P. aeruginosa isolates from COPD sputa have been comprehensively explored by susceptibility testing, comparative-genomic evaluation, phylogenetic evaluation, phenotypic profiling, and comparative-transcriptomic evaluation. We discovered that P. aeruginosa was prevalent in elder COPD sufferers and extremely resisted to many generally used antibiotics. P. aeruginosa COPD isolates harbored a considerable variety of variant websites which may affect the first metabolism and substance transport system.
Recombinant Genome polyprotein |
|||
| MBS1236293-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 935 |
Recombinant Genome polyprotein |
|||
| MBS1141323-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 875 |
Recombinant Genome polyprotein |
|||
| MBS1141323-005mgEColi | MyBiosource | 0.05mg(E-Coli) | EUR 490 |
Recombinant Genome polyprotein |
|||
| MBS1141323-005mgYeast | MyBiosource | 0.05mg(Yeast) | EUR 690 |
Recombinant Genome polyprotein |
|||
| MBS1141323-02mgEColi | MyBiosource | 0.2mg(E-Coli) | EUR 640 |
Recombinant Genome polyprotein |
|||
| MBS1141323-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 695 |
Recombinant Genome polyprotein |
|||
| MBS1257473-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 990 |
Recombinant Genome polyprotein |
|||
| MBS1257473-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 555 |
Recombinant Genome polyprotein |
|||
| MBS1257473-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 745 |
Recombinant Genome polyprotein |
|||
| MBS1257473-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 665 |
Recombinant Genome polyprotein |
|||
| MBS1257473-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 870 |
Recombinant Genome polyprotein |
|||
| MBS1068339-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 990 |
Recombinant Genome polyprotein |
|||
| MBS1068339-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 555 |
Recombinant Genome polyprotein |
|||
| MBS1068339-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 745 |
Recombinant Genome polyprotein |
|||
| MBS1068339-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 665 |
Recombinant Genome polyprotein |
|||
| MBS1068339-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 870 |
Recombinant Genome polyprotein |
|||
| MBS1040920-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1045 |
Recombinant Genome polyprotein |
|||
| MBS1040920-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 620 |
Recombinant Genome polyprotein |
|||
| MBS1040920-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 795 |
Recombinant Genome polyprotein |
|||
| MBS1040920-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 720 |
Recombinant Genome polyprotein |
|||
| MBS1040920-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 930 |
Recombinant JEV Genome polyprotein (aa 2528-3432) Protein |
|||
| VAng-Wyb3447-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 9926.4 |
|
Description: Japanese encephalitis virus (strain Jaoars982) Genome polyprotein, recombinant protein. |
|||
Recombinant YFV Genome polyprotein Protein (aa 286-730) |
|||
| VAng-Cr6541-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5751.6 |
|
Description: YFV Genome polyprotein, partial, recombinant protein. |
|||
Recombinant YFV Genome polyprotein Protein (aa 286-730) |
|||
| VAng-Cr6541-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3657.6 |
|
Description: YFV Genome polyprotein, partial, recombinant protein. |
|||
Recombinant YFV Genome polyprotein Protein (aa 286-730) |
|||
| VAng-Cr6541-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1083.6 |
|
Description: YFV Genome polyprotein, partial, recombinant protein. |
|||
Recombinant YFV Genome polyprotein Protein (aa 1-101) |
|||
| VAng-Cr6542-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3408 |
|
Description: YFV Genome polyprotein, recombinant protein. |
|||
Recombinant YFV Genome polyprotein Protein (aa 1-101) |
|||
| VAng-Cr6542-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2452.8 |
|
Description: YFV Genome polyprotein, recombinant protein. |
|||
Recombinant YFV Genome polyprotein Protein (aa 1-101) |
|||
| VAng-Cr6542-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1693.2 |
|
Description: YFV Genome polyprotein, recombinant protein. |
|||
Recombinant human Genome polyprotein |
|||
| MBS960928-005mg | MyBiosource | 0.05mg | EUR 695 |
Recombinant human Genome polyprotein |
|||
| MBS960928-02mg | MyBiosource | 0.2mg | EUR 905 |
Recombinant human Genome polyprotein |
|||
| MBS960928-05mg | MyBiosource | 0.5mg | EUR 990 |
Recombinant human Genome polyprotein |
|||
| MBS960928-1mg | MyBiosource | 1mg | EUR 1355 |
Recombinant HCV Genome polyprotein protein, N- GST Tag |
|||
| MBS157516-005mg | MyBiosource | 0.05mg | EUR 320 |
Recombinant HCV Genome polyprotein protein, N- GST Tag |
|||
| MBS157516-01mg | MyBiosource | 0.1mg | EUR 410 |
Recombinant HCV Genome polyprotein protein, N- GST Tag |
|||
| MBS157516-5x01mg | MyBiosource | 5x0.1mg | EUR 1520 |
Recombinant Genome polyprotein, partial |
|||
| MBS1088414-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Genome polyprotein, partial |
|||
| MBS1014881-INQUIRE | MyBiosource | INQUIRE | Ask for price |
OPCA05394-20UG - GENOME POLYPROTEIN Recombinant Protein (isolate 1) |
|||
| OPCA05394-20UG | Aviva Systems Biology | 20ug | EUR 339 |
Recombinant CSFV Genome polyprotein protein, N-His Tag |
|||
| MBS156846-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant CSFV Genome polyprotein protein, N-His Tag |
|||
| MBS156846-01mg | MyBiosource | 0.1mg | EUR 450 |
Recombinant CSFV Genome polyprotein protein, N-His Tag |
|||
| MBS156846-5x01mg | MyBiosource | 5x0.1mg | EUR 1710 |
Recombinant YFV Genome polyprotein (NS4A) Protein (aa 1-3412) |
|||
| VAng-Cr6545-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: YFV (isolate Uganda/A7094A4/1948) Genome polyprotein (NS4A), recombinant protein. |
|||
Recombinant Senecavirus A Genome polyprotein protein, No Tag |
|||
| MBS156947-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Senecavirus A Genome polyprotein protein, No Tag |
|||
| MBS156947-01mg | MyBiosource | 0.1mg | EUR 450 |
Recombinant Senecavirus A Genome polyprotein protein, No Tag |
|||
| MBS156947-5x01mg | MyBiosource | 5x0.1mg | EUR 1710 |
Recombinant Senecavirus A Genome polyprotein protein, No Tag |
|||
| MBS156948-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Senecavirus A Genome polyprotein protein, No Tag |
|||
| MBS156948-01mg | MyBiosource | 0.1mg | EUR 450 |
Recombinant Senecavirus A Genome polyprotein protein, No Tag |
|||
| MBS156948-5x01mg | MyBiosource | 5x0.1mg | EUR 1710 |
Recombinant Hepatitis C Genome polyprotein |
|||
| CSB-RP184674Ba | Cusabio | 5430 mg | Ask for price |
Recombinant Hepatitis C Genome polyprotein |
|||
| CSB-RP184674Ba-20ug | Cusabio | 20ug | Ask for price |
|
Description: 1-631aa |
|||
Recombinant Langat virus Genome polyprotein |
|||
| MBS1133753-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Echovirus 11 Genome polyprotein |
|||
| MBS1164799-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1205 |
Recombinant Echovirus 11 Genome polyprotein |
|||
| MBS1164799-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Echovirus 11 Genome polyprotein |
|||
| MBS1164799-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 995 |
Recombinant Echovirus 11 Genome polyprotein |
|||
| MBS1164799-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1035 |
Recombinant Echovirus 11 Genome polyprotein |
|||
| MBS1164799-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
Recombinant Echovirus 16 Genome polyprotein |
|||
| MBS1346831-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1205 |
Recombinant Echovirus 16 Genome polyprotein |
|||
| MBS1346831-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Echovirus 16 Genome polyprotein |
|||
| MBS1346831-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 995 |
Recombinant Echovirus 16 Genome polyprotein |
|||
| MBS1346831-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1035 |
Recombinant Echovirus 16 Genome polyprotein |
|||
| MBS1346831-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
Recombinant Echovirus 12 Genome polyprotein |
|||
| MBS1285198-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1205 |
Recombinant Echovirus 12 Genome polyprotein |
|||
| MBS1285198-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Echovirus 12 Genome polyprotein |
|||
| MBS1285198-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 995 |
Recombinant Echovirus 12 Genome polyprotein |
|||
| MBS1285198-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1030 |
Recombinant Echovirus 12 Genome polyprotein |
|||
| MBS1285198-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
Recombinant Echovirus 6 Genome polyprotein |
|||
| MBS1393297-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1205 |
Recombinant Echovirus 6 Genome polyprotein |
|||
| MBS1393297-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Echovirus 6 Genome polyprotein |
|||
| MBS1393297-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 995 |
Recombinant Echovirus 6 Genome polyprotein |
|||
| MBS1393297-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1030 |
Recombinant Echovirus 6 Genome polyprotein |
|||
| MBS1393297-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
Recombinant Echovirus 1 Genome polyprotein |
|||
| MBS1036392-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1205 |
Recombinant Echovirus 1 Genome polyprotein |
|||
| MBS1036392-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Echovirus 1 Genome polyprotein |
|||
| MBS1036392-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 995 |
Recombinant Echovirus 1 Genome polyprotein |
|||
| MBS1036392-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1030 |
Recombinant Echovirus 1 Genome polyprotein |
|||
| MBS1036392-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
Recombinant Echovirus 9 Genome polyprotein |
|||
| MBS1369865-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1205 |
Recombinant Echovirus 9 Genome polyprotein |
|||
| MBS1369865-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Echovirus 9 Genome polyprotein |
|||
| MBS1369865-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 995 |
Recombinant Echovirus 9 Genome polyprotein |
|||
| MBS1369865-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1030 |
Recombinant Echovirus 9 Genome polyprotein |
|||
| MBS1369865-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
Recombinant Echovirus 9 Genome polyprotein |
|||
| MBS1461867-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1205 |
Recombinant Echovirus 9 Genome polyprotein |
|||
| MBS1461867-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Echovirus 9 Genome polyprotein |
|||
| MBS1461867-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 995 |
Recombinant Echovirus 9 Genome polyprotein |
|||
| MBS1461867-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1030 |
Recombinant Echovirus 9 Genome polyprotein |
|||
| MBS1461867-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
Recombinant Echovirus 30 Genome polyprotein |
|||
| MBS1479634-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 1120 |
Recombinant Echovirus 30 Genome polyprotein |
|||
| MBS1479634-005mgEColi | MyBiosource | 0.05mg(E-Coli) | EUR 860 |
Recombinant Echovirus 30 Genome polyprotein |
|||
| MBS1479634-005mgYeast | MyBiosource | 0.05mg(Yeast) | EUR 995 |
Recombinant Echovirus 30 Genome polyprotein |
|||
| MBS1479634-02mgEColi | MyBiosource | 0.2mg(E-Coli) | EUR 1120 |
Recombinant Echovirus 30 Genome polyprotein |
|||
| MBS1479634-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 1225 |
Recombinant Langat virus Genome polyprotein |
|||
| MBS7038287-002mg | MyBiosource | 0.02mg | EUR 1845 |
Recombinant Langat virus Genome polyprotein |
|||
| MBS7038287-01mg | MyBiosource | 0.1mg | EUR 2775 |
Recombinant Langat virus Genome polyprotein |
|||
| MBS7038287-5x01mg | MyBiosource | 5x0.1mg | EUR 12450 |
Recombinant Hepatitis C Genome polyprotein |
|||
| RPC24458-100ug | Biomatik Corporation | 100ug | EUR 721.6 |
Recombinant Hepatitis C Genome polyprotein |
|||
| RPC24458-20ug | Biomatik Corporation | 20ug | EUR 448.1 |
Recombinant Senecavirus A Genome polyprotein protein, C-His Tag |
|||
| MBS157116-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Senecavirus A Genome polyprotein protein, C-His Tag |
|||
| MBS157116-01mg | MyBiosource | 0.1mg | EUR 450 |
Recombinant Senecavirus A Genome polyprotein protein, C-His Tag |
|||
| MBS157116-5x01mg | MyBiosource | 5x0.1mg | EUR 1710 |
Recombinant Senecavirus A Genome polyprotein protein, C-His Tag |
|||
| MBS157181-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Senecavirus A Genome polyprotein protein, C-His Tag |
|||
| MBS157181-01mg | MyBiosource | 0.1mg | EUR 450 |
Recombinant Senecavirus A Genome polyprotein protein, C-His Tag |
|||
| MBS157181-5x01mg | MyBiosource | 5x0.1mg | EUR 1710 |
Recombinant Senecavirus A Genome polyprotein protein, C-His Tag |
|||
| MBS1562943-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Senecavirus A Genome polyprotein protein, C-His Tag |
|||
| MBS1562943-01mg | MyBiosource | 0.1mg | EUR 450 |
Recombinant Senecavirus A Genome polyprotein protein, C-His Tag |
|||
| MBS1562943-5x01mg | MyBiosource | 5x0.1mg | EUR 1710 |
Recombinant Echo 9 virus Genome polyprotein |
|||
| MBS1066973-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 880 |
Recombinant Echo 9 virus Genome polyprotein |
|||
| MBS1066973-005mgEColi | MyBiosource | 0.05mg(E-Coli) | EUR 500 |
Recombinant Echo 9 virus Genome polyprotein |
|||
| MBS1066973-005mgYeast | MyBiosource | 0.05mg(Yeast) | EUR 700 |
Recombinant Echo 9 virus Genome polyprotein |
|||
| MBS1066973-02mgEColi | MyBiosource | 0.2mg(E-Coli) | EUR 655 |
Recombinant Echo 9 virus Genome polyprotein |
|||
| MBS1066973-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 700 |
Recombinant Enterovirus A71 Genome polyprotein protein, N-His Tag |
|||
| MBS157180-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Enterovirus A71 Genome polyprotein protein, N-His Tag |
|||
| MBS157180-01mg | MyBiosource | 0.1mg | EUR 450 |
Recombinant Enterovirus A71 Genome polyprotein protein, N-His Tag |
|||
| MBS157180-5x01mg | MyBiosource | 5x0.1mg | EUR 1710 |
Recombinant Coxsackievirus B4 Genome polyprotein |
|||
| MBS1166653-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1205 |
Recombinant Coxsackievirus B4 Genome polyprotein |
|||
| MBS1166653-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Coxsackievirus B4 Genome polyprotein |
|||
| MBS1166653-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 995 |
Recombinant Coxsackievirus B4 Genome polyprotein |
|||
| MBS1166653-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1030 |
Recombinant Coxsackievirus B4 Genome polyprotein |
|||
| MBS1166653-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
Recombinant Coxsackievirus B3 Genome polyprotein |
|||
| MBS1106207-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1210 |
Recombinant Coxsackievirus B3 Genome polyprotein |
|||
| MBS1106207-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Coxsackievirus B3 Genome polyprotein |
|||
| MBS1106207-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1000 |
Recombinant Coxsackievirus B3 Genome polyprotein |
|||
| MBS1106207-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1035 |
Recombinant Coxsackievirus B3 Genome polyprotein |
|||
| MBS1106207-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
Recombinant Coxsackievirus A9 Genome polyprotein |
|||
| MBS1261214-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1205 |
Recombinant Coxsackievirus A9 Genome polyprotein |
|||
| MBS1261214-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Coxsackievirus A9 Genome polyprotein |
|||
| MBS1261214-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 995 |
Recombinant Coxsackievirus A9 Genome polyprotein |
|||
| MBS1261214-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1030 |
Recombinant Coxsackievirus A9 Genome polyprotein |
|||
| MBS1261214-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
Recombinant Coxsackievirus B1 Genome polyprotein |
|||
| MBS1049458-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1210 |
Recombinant Coxsackievirus B1 Genome polyprotein |
|||
| MBS1049458-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Coxsackievirus B1 Genome polyprotein |
|||
| MBS1049458-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1000 |
Recombinant Coxsackievirus B1 Genome polyprotein |
|||
| MBS1049458-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1035 |
Recombinant Coxsackievirus B1 Genome polyprotein |
|||
| MBS1049458-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
Recombinant Coxsackievirus B4 Genome polyprotein |
|||
| MBS1455843-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 1120 |
Recombinant Coxsackievirus B4 Genome polyprotein |
|||
| MBS1455843-005mgEColi | MyBiosource | 0.05mg(E-Coli) | EUR 860 |
Recombinant Coxsackievirus B4 Genome polyprotein |
|||
| MBS1455843-005mgYeast | MyBiosource | 0.05mg(Yeast) | EUR 995 |
Recombinant Coxsackievirus B4 Genome polyprotein |
|||
| MBS1455843-02mgEColi | MyBiosource | 0.2mg(E-Coli) | EUR 1120 |
Recombinant Coxsackievirus B4 Genome polyprotein |
|||
| MBS1455843-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 1225 |
Recombinant Coxsackievirus B6 Genome polyprotein |
|||
| MBS1374038-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 1120 |
Recombinant Coxsackievirus B6 Genome polyprotein |
|||
| MBS1374038-005mgEColi | MyBiosource | 0.05mg(E-Coli) | EUR 860 |
Recombinant Coxsackievirus B6 Genome polyprotein |
|||
| MBS1374038-005mgYeast | MyBiosource | 0.05mg(Yeast) | EUR 995 |
Recombinant Coxsackievirus B6 Genome polyprotein |
|||
| MBS1374038-02mgEColi | MyBiosource | 0.2mg(E-Coli) | EUR 1120 |
Recombinant Coxsackievirus B6 Genome polyprotein |
|||
| MBS1374038-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 1225 |
Recombinant Coxsackievirus B2 Genome polyprotein |
|||
| MBS1480288-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 1125 |
These isolates have been discretely distributed within the phylogenetic tree and clustered with internationally collected P. aeruginosa in two main teams, and might be labeled into three teams in keeping with their variations in virulence-related phenotypes. Moreover, the transcriptional patterns of COPD isolates might be labeled into PAO1-like group with decreased protein secretion and motility and PAO1-distinct group with decreased substance transport however enhanced major metabolism. In conclusion, this examine demonstrates that P. aeruginosa isolates from COPD sufferers have ample genetic and phenotypic variety, and offers an necessary reference for additional exploring the survival technique of P. aeruginosa in COPD airways and the event of anti-pseudomonal remedy.
